Circulating tumor DNA–guided adjuvant immunotherapy in muscle-invasive bladder cancer
Bladder Cancer · 2026-01 · 12 (1)
DOI: 10.1177/23523735261429862 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bladder Cancer, online erschienen am 02.03.2026. Verfasst von Kamil Malshy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Rochester Medical Center, Rochester, NY, USA. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The rationale for adjuvant therapy after radical cystectomy
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, University of Rochester Medical Center, Rochester, NY, USA.
Zitieren
APA
Malshy, K., & Messing, E. M. (2026). Circulating tumor DNA–guided adjuvant immunotherapy in muscle-invasive bladder cancer. Bladder Cancer, 12(1). https://doi.org/10.1177/23523735261429862
Vancouver
Malshy K, Messing EM. Circulating tumor DNA–guided adjuvant immunotherapy in muscle-invasive bladder cancer. Bladder Cancer. 2026;12(1). doi:10.1177/23523735261429862
BibTeX
@article{Malshy2026,
author = {Malshy, Kamil and Messing, Edward M},
title = {Circulating tumor DNA–guided adjuvant immunotherapy in muscle-invasive bladder cancer},
journal = {Bladder Cancer},
year = {2026},
volume = {12},
number = {1},
doi = {10.1177/23523735261429862}
}
EUVIMED